VT H 859

died on adjournment

An act relating to psychedelic therapy and clinical drug development trials

Vermont · 2026 Regular Session · lower

Quick answers

Did VT H 859 pass?

No. VT H 859 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-03): Read first time and referred to the Committee on Health Care

What is VT H 859 about?

VT H 859 is a bill in the 2026 Regular Session titled “An act relating to psychedelic therapy and clinical drug development trials”.

Who sponsors VT H 859?

Jubilee McGill, Kate Logan, Bram Kleppner and 3 others are the primary sponsors of VT H 859.

Introduced: 2026-02-03
Latest action: 2026-02-03 — Read first time and referred to the Committee on Health Care
Bill type: bill
Last updated: —

Committees

Not provided by source.

Action timeline

2026-02-03
Read first time and referred to the Committee on Health Care
introduction

Versions

As IntroducedOpens in a new windowCompare
(document, no version)Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

http://legislature.vermont.gov/bill/loadBillRollCalls/2026/1845

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:36:51.365595Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changes Status and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=VT&identifier=H 859. See the API docs or the MCP server for AI assistants.

Known limitations

Sponsor party and chamber affiliation are not yet captured by this API.
Committee referrals are not yet captured.

See the methodology page for data sources and limitations.